Condition: Non-Small-Cell Lung Cancer
Intervention: Drug: Zoledronic acid 4 mg
Sponsor: Novartis Pharmaceuticals
Completed - verified August 2011
By ClinicalTrials.gov 
The independent gateway for the orthopaedic community. Connecting professionals and patients since 1999.